• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEODENT - JJGC S.A. CM TITAMAX EX ACQUA IMPLANT 4.0X17; ENDOSSEOUS DENTAL IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEODENT - JJGC S.A. CM TITAMAX EX ACQUA IMPLANT 4.0X17; ENDOSSEOUS DENTAL IMPLANT Back to Search Results
Catalog Number 140.640
Medical Device Problem Codes Failure to Osseointegrate (1863); Loss of Osseointegration (2408)
Health Effect - Clinical Codes Failure of Implant (1924); Pain (1994); Tissue Damage (2104)
Date of Event 08/06/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Exemption number: e2015015.Instradent usa, inc is submitting the report on behalf of neodent - jjgc.
 
Event or Problem Description
The clinician reported that nearly 1 year after the dental implant and abutment were placed in ada site 23 in the mouth, the implant lost osseointegration in type ii bone.Clinician reports patient's pain.The product will be forwarded to the manufacturer for investigation.There were no reported post-operative complications.
 
Additional Manufacturer Narrative
Exemption number: e2015015.Instradent usa, inc is submitting the report on behalf of neodent - jjgc.After the evaluation, the event was considered as osseointegration failure.Considering the surgical methodology, it was seen that the dentist has selected an implant design which is not recommended for the patient's bone quality.Moreover, it was seen that the dentist has used more drills than recommended to perform the implant installation.The dentist reported that immediate load and immediate implant procedures were performed.
 
Event or Problem Description
The clinician reported that nearly 1 year after the dental implant and abutment were placed in ada site 23 in the mouth, the implant lost osseointegration in type ii bone.Clinician reports patient's pain.The product will be forwarded to the manufacturer for investigation.There were no reported post-operative complications.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CM TITAMAX EX ACQUA IMPLANT 4.0X17
Common Device Name
ENDOSSEOUS DENTAL IMPLANT
Manufacturer (Section D)
NEODENT - JJGC S.A.
av. juscelino kubitschek de
oliveira, 3291 cic
curitiba PR 81270 -200
BR  81270-200
MDR Report Key7883223
Report Number3008261720-2018-04608
Device Sequence Number13930309
Product Code DZE
UDI-Device Identifier07899878016595
UDI-Public07899878016595
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K133592
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2018
Reporter Type Manufacturer
Report Source distributor,foreign
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/17/2018
Report Date (Section F) 08/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/28/2019
Device Catalogue Number140.640
Device Lot Number90212
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/27/2018
Was the Report Sent to FDA? No
Distributor Facility Aware Date11/30/2018
Device Age1 MO
Event Location Other
Date Report to Manufacturer08/27/2018
Initial Date Received by Manufacturer 08/27/2018
Supplement Date Received by Manufacturer11/12/2018
Initial Report FDA Received Date09/17/2018
Supplement Report FDA Received Date11/30/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ABUTMENT REMOVAL; ABUTMENT REMOVAL
Outcome Attributed to Adverse Event Required Intervention;
Patient Age47 YR
-
-